Exhibit 99.2
            
                     STI/BBC Merger Creates New Medical Device
                      Company `Meridian Medical Technologies'
            
            
   ROCKVILLE, Md., Nov. 21 /PR Newswire/ -- Survival Technology, Inc. (STI) 
(Nasdaq: STIQ) and Brunswick Biomedical Corporation (BBC) today announced 
they completed their previously announced merger to form Meridian Medical 
Technologies, Inc.  The company's new Nasdaq ticker symbol is MTEC effective 
November 22, 1996 (Nasdaq: MTEC).

    "The mission of Meridian Medical Technologies is to be a global leader in 
early intervention home healthcare and emergency medical technologies," said 
James H. Miller, chairman, president and CEO.  "The Meridian name reflects 
our commitment to reaching new heights in these key growth segments of the 
medical device industry."
            
    He noted that the combining of resources creates new opportunities for 
growth in both drug delivery systems and cardiopulmonary products and 
services, STI is the world leader in auto-injector drug delivery technology 
for pharmaceuticals, biotechnology products and the military.  Brunswick 
develops, manufactures and markets emergency-care products and medical 
devices for the non-invasive monitoring, diagnosis and care of cardiac 
patients.

    "We are optimistic about the exciting prospects for growth, synergy and 
new technological advances in the years ahead," Mr. Miller said.  During 
fiscal 1996 ended July 31, 1996, STIQ sales increased 23 percent over the 
previous year to $31.4 million, while earnings increased 177 percent to $1.3 
million ($.41 per share).

    Meridian Medical Technologies' facilities will include the former STI 
manufacturing complex in St. Louis, offices in Rockville and international 
operations based in England as well as the former Brunswick facilities in 
Wareham, Mass. and Northern Ireland.
            
    Pursuant to the definitive agreement, each of Brunswick's outstanding 
shares of common stock was converted into 2.1 shares of the company's common 
stock.  Each of Brunswick's outstanding shares of preferred stock was 
converted into 2.1 shares of the company's common stock and a warrant to 
purchase 0.4 of a share of the company's common stock at an exercise price of 
$11.00 per share, exercisable for a period of five years following the merger.

                                   33








    In addition, the company assumed Brunswick's obligations under 
outstanding options and warrants.  These provisions of the agreement resulted 
in approximately 1.7 million shares of the company's common stock being 
issued in exchange for the Brunswick stock upon the consummation of the 
merger and could result in the issuance of an additional 1.05 million shares 
of the company's common stock if all options and warrants are exercised and 
the required consideration paid.  Each of the 1,888,126 shares of the 
company's common stock formerly owned by Brunswick was retired in the merger. 
The transaction is being accounted for by the purchase method of accounting.

SOURCE  Survival Technology, Inc.
        -0- 11/21/96
        /CONTACT:  James H. Miller, Chairman, President and 
CEO or Jeffrey W. Church, Sr. Vice President, Finance and 
CFO, 800-638-8093, both of Survival Technology/































                                   34